Brief: Scisparc Announces Closing Of The Sale To N2off Of Majority-Owned Subsidiary Mitocarex, Advancing Drug Discovery For Resistant Cancers Including Pancreatic And Non-Small Cell Lung Cancer
23/10/2025 23:38
Oct 24 (Reuters) - N2OFF Inc NITO.O: SCISPARC ANNOUNCES CLOSING OF THE SALE TO N2OFF OF MAJORITY-OWNED SUBSIDIARY MITOCAREX, ADVANCING DRUG DISCOVERY FOR RESISTANT CANCERS INCLUDING PANCREATIC AND NON-SMALL CELL LUNG CANCER Source text: ID:nGNX67TWX1 Further company coverage: NITO.O ((Reuters.Briefs@thomsonreuters.com;))